A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma
Clinical trial NCT03730142 · COMPLETED
Trial details
- NCT number
- NCT03730142
- Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2020-07-25
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.